These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 455721)

  • 21. Sequential urinary N tau-methylhistidine to creatinine ratios in premature infants.
    Burgoyne JL; Fitzgerald A; Dahlenburg GW; Haslam RR; Tomas FM; Ballard FJ
    Muscle Nerve; 1986 Jan; 9(1):24-9. PubMed ID: 3951478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study of urinary creatinine and creatine in progressive muscular dystrophy].
    Sato N; Kanno M; Annaka S
    Iryo; 1968 Dec; 22(12):1372-8. PubMed ID: 5717703
    [No Abstract]   [Full Text] [Related]  

  • 23. [Urinary excretion of methylamino acids in myogenic and neurogenic muscular atrophy (author's transl)].
    Inoue R
    Rinsho Shinkeigaku; 1980 Jul; 20(7):510-5. PubMed ID: 7460420
    [No Abstract]   [Full Text] [Related]  

  • 24. 3-Methylhistidine/creatinine ratio in urine from low-birth-weight infants. Statistical analysis.
    Hülsemann J; Wember T; Kordass U; Sander G; Schmidt E; Schöch G
    Ann Nutr Metab; 1988; 32(1):38-43. PubMed ID: 3355110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of exercise on protein degradation: 3-methylhistidine and creatinine excretion.
    Radha E; Bessman SP
    Biochem Med; 1983 Feb; 29(1):96-100. PubMed ID: 6838503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary 3-methylhistidine derivative as indicator of nutrients intake in low-birth-weight infants.
    Gil A; Faus MJ; Robles R; Pita ML; Sánchez-Pozo A; Linares MD; Sánchez-Medina F
    Horm Metab Res; 1984 Dec; 16(12):667-70. PubMed ID: 6526369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-Methylhistidine/creatinine ratio in urine from low-birth-weight infants. Clinical approach.
    Hülsemann J; Kordass U; Sander G; Schmidt E; Schöch G
    Ann Nutr Metab; 1988; 32(1):44-51. PubMed ID: 3355111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of the composition of the diet on the excretion of 3-methylhistidine and creatinine in urine].
    Neuhäuser M; Göttmann U; Bässler KH
    J Clin Chem Clin Biochem; 1984 Nov; 22(11):731-4. PubMed ID: 6527093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal diagnosis of Duchenne muscular dystrophy: failure of amniotic fluid and maternal serum N tau-methylhistidine analyses to detect affected fetuses.
    Wassner SJ; Li JB; Ladda RL; Lorenz RP; Emery AE
    Am J Obstet Gynecol; 1982 May; 143(2):216-9. PubMed ID: 7081334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carrier detection in Duchenne muscular dystrophy. Evidence from a study of obligatory carriers and mothers of isolated cases.
    Sibert JR; Harper PS; Thompson RJ; Newcombe RG
    Arch Dis Child; 1979 Jul; 54(7):534-7. PubMed ID: 485196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in urinary 3-methylhistidine/creatinine ratio in human subjects after strenuous exercise.
    Dohm GL; Israel RG; Breedlove RL; Askew EW
    Prog Clin Biol Res; 1985; 180():607-9. PubMed ID: 4034564
    [No Abstract]   [Full Text] [Related]  

  • 32. Carrier detection in Duchenne muscular dystrophy.
    Fitzsimmons JS; McLachlan JI; Reeves WG; Marriott DW; Woolfson AM; Mayhew J
    J Med Genet; 1980 Jun; 17(3):165-9. PubMed ID: 7401126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy.
    Stewart PM; Walser M; Drachman DB
    Muscle Nerve; 1982 Mar; 5(3):197-201. PubMed ID: 7088016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Creatine kinase activity in the detection of carriers of Duchenne muscular dystrophy: comparison of two methods.
    Tippett PA; Dennis NR; Machin D; Price CP; Clayton BE
    Clin Chim Acta; 1982 Jun; 121(3):345-59. PubMed ID: 7105400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of the determination of urinary 3-methylhistidine (3 MEHIS) in the evaluation of postoperative muscular catabolism].
    François G; Blanc M; Blache JL; Granthil C; Rose F
    Ann Anesthesiol Fr; 1981; 22(4):339-45. PubMed ID: 6119943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muscle protein breakdown in thyrotoxicosis assessed by urinary 3-methylhistidine excretion.
    Yates RO; Connor H; Woods HF
    Ann Nutr Metab; 1981; 25(4):262-7. PubMed ID: 7305291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carrier detection in Duchenne muscular dystrophy: Assessment of the effect of age on detection-rate with serum-creatine-kinase-activity.
    Nicholson GA; Gardner-Medwin D; Pennington RJ; Walton JN
    Lancet; 1979 Mar; 1(8118):692-4. PubMed ID: 85935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy.
    Takahashi K; Shutta K; Matsuo B; Takai T; Takao H; Imura H
    Clin Chim Acta; 1977 Mar; 75(3):435-42. PubMed ID: 852132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of neosteron on creatine excretion in muscular dystrophy].
    BACH I; FELIX J; GARAS Z; KOMOR K; POPPER Z
    Magy Belorv Arch (1955); 1955 Aug; 8(4):106-8. PubMed ID: 13287290
    [No Abstract]   [Full Text] [Related]  

  • 40. Urinary excretion of 3-methylhistidine as an index of protein nutrition in total parenteral nutrition.
    Kim CW; Okada A; Itakura T; Takagi Y; Nakao K; Kawashima Y
    JPEN J Parenter Enteral Nutr; 1988; 12(2):198-204. PubMed ID: 3129597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.